299217-30-4 Usage
Physical State
Clear, colorless liquid at room temperature
Solubility
Insoluble in water, soluble in organic solvents
Uses
Commonly used as a reagent in organic synthesis, primarily used as an alkylating agent in the production of pharmaceuticals and chemical intermediates
Potential Medical Applications
Has shown potential as an anticonvulsant and anti-inflammatory agent in preclinical studies
Reactivity
Highly reactive compound, should be handled with caution in laboratory settings
Derivative
Brominated derivative of acetophenone
Check Digit Verification of cas no
The CAS Registry Mumber 299217-30-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,9,2,1 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 299217-30:
(8*2)+(7*9)+(6*9)+(5*2)+(4*1)+(3*7)+(2*3)+(1*0)=174
174 % 10 = 4
So 299217-30-4 is a valid CAS Registry Number.
299217-30-4Relevant academic research and scientific papers
PRODRUGS OF OXAZOLIDINONE CETP INHIBITORS
-
Page/Page column 12, (2010/04/27)
The compounds of Formula I are prodrugs of CETP inhibitors having a central oxazolidinone ring. The compounds cyclize by the elimination of HX to form an oxazolidinone ring after administration to a patient.
Dendroid peptide structural mimetics of ω-conotoxin MVIIA based on a 2(1H)-quinolinone core
Guo, Zhao-Xia,Cammidge, Andrew N.,Horwell, David C.
, p. 5169 - 5175 (2007/10/03)
Three mimetics of the peptide ω-Conotoxin MVIIA have been synthesised following the dendroid approach. The three key central amino acids of the natural peptide are mimicked by phenylguanidine (arginine), isopentyl (leucine) and aryl alcohol (tyrosine) att
